Table of contents  by unknown
Vol. 145, No. 3S, March 2013Table of ContentsS1 Introduction(continued on page 4A
The Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 3S 3ARandall B. Griepp, MD, and Steven L. Lansman, MD, PhD, New York and Valhalla, NYPanel 1 S2 Medical management of thoracic aortic aneurysm disease
Alan C. Braverman, MD, St Louis, MoMedical management for the patient with thoracic aortic aneurysm disease includes establishing the
correct diagnosis, pharmacologic therapy (usually with beta-blockers), lifestyle modification to
lessen stress on the aorta, and imaging surveillance of the aorta.S7 Frailty and aortic valve disease
Michael Mack, MD, Plano, TexFrailty is a common occurrence in elderly patients with aortic stenosis being considered for
interventional or surgical therapy. In addition to risk prediction algorithms, measurement of frailty
by a 5-m walk test and other objective parameters is helpful to determine the true risk and benefit of
therapy.S11 A comprehensive review of the PARTNER trial
Lars G. Svensson, MD, PhD, Murat Tuzcu, MD, Samir Kapadia, MD, Eugene H. Blackstone, MD,
Eric E. Roselli, MD, A. Marc Gillinov, MD, Joseph F. Sabik III, MD, and Bruce W. Lytle, MD,
Cleveland, OhioPercutaneous transcatheter aortic valve replacement was introduced in 2002, but its effectiveness
remained to be assessed. The results of the PARTNER A and B trials showed that with the current
device iteration, survival has been remarkably good, but stroke and perivalvular leakage require
further technique and device development.S17 Transcatheter aortic valve implantation: The European experience
R€udiger Lange, MD, PhD, Sabine Bleiziffer, MD, Yacine Elhmidi, MD, and
Nicolo Piazza, MD, PhD, Munich, Germany, and Montreal, Quebec, CanadaThe European transcatheter aortic valve implantation experience began in 2002. The article
summarizes experience with various access routes and valve-in-surgical bioprosthetic valve
procedures, market and reimbursement strategies in the different European countries, data from the
major industry sponsored European studies, from single-center studies and European registries, and
also provides an overview of important future studies.)
Table of Contents (continued)SThe opinions or views expressed in this
dations of The American Association fo
Dosages, indications, and methods of us
derived from the professional literature
animal models and clinical data in huma
4A The Journal of Thoracic and22 Long-term results of aortic root repair using the reimplantation technique(continued on page 5A
professional education supplement are those of the authors and do not necessarily reflect the opinions or recommen
r Thoracic Surgery.
e for products that are referred to in the supplement by the authors may reflect their clinical experience or may b
or other clinical sources. Because of the differences between in vitro and in vivo systems and between laborator
ns, in vitro and animal data may not necessarily correlate with clinical results.
Cardiovascular Surgery c March 2013Tirone E. David, MD, Susan Armstrong, MSc, Cedric Manlhiot, BSc,
Brian W. McCrindle, MD, MPH, and Christopher M. Feindel, MD, Toronto, Ontario, CanadaReimplantation of the aortic valve for treatment of aortic root aneurysm was associated with a
15-year freedom from reoperation on the aortic valve of 97.8% 6 5.3% and a freedom from
moderate or severe aortic insufficiency of 89.4% 6 12%.S26 Principles of aortic valve repair
Gebrine El Khoury, MD, and Laurent de Kerchove, MD, Brussels, BelgiumThis article attempts to describe the important principles of aortic valve repair by focusing on
functional anatomy, surgical techniques for cusp repair, and outcome. In the term aortic valve
repair, we include not only the repair of the cusp but also the valve-sparing root replacement or any
kind of functional aortic annulus stabilization.S30 Early resultswith annular support in reconstruction of the bicuspid aortic valve
Diana Aicher, MD, Ulrich Schneider, Wolfram Schmied, Dipl Psych, Takashi Kunihara, MD,
Masato Tochii, MD, and Hans-Joachim Sch€afers, MD, PhD, Homburg/Saar, GermanyDilatation of the AVJ has been identified as a risk factor for repair failure in aortic valves. We have
used suture annuloplasty to correct AVJ enlargement (.27mm). Application of suture annuloplasty
improved 3-year freedom from reoperation after isolated repair in BAV from 84% to 92% (P5 .07).S35 Tirone David valve-sparing aortic root replacement and cusp repair for
bicuspid aortic valve disease
Fabian A. Kari, MD, David H. Liang, MD, PhD, John-Peder Escobar Kvitting, MD, PhD,
Elizabeth H. Stephens, MD, PhD, R. Scott Mitchell, MD, Michael P. Fischbein, MD, PhD, and
D. Craig Miller, MD, Stanford, CalifSeventy-five patients (aged 456 10 years) with bicuspid aortic valves undergoing Tirone David
valve-sparing aortic root replacement (66% with aortic cusp repair) were analyzed. Survival,
freedom from reoperation, and aortic regurgitation greater than 2+ were 99%, 90%, and 100%,
respectively, at 3 to 5 years. Longer follow-upwill determine the ultimate durability of this approach.S41 Long-term survival after composite mechanical aortic root replacement:
A consecutive series of 448 cases
Christian D. Etz, MD, PhD, Konstantin von Aspern, MD, Felix F. Girrbach, MD,
Roberto R. Battellini, MD, PhD, Oemuer Akhavuz, MD, Sergey Leontyev, MD,
Michael A. Borger, MD, PhD, Pascal M. Dohmen, MD, PhD, and
Friedrich-Wilhelm Mohr, MD, PhD, Saxony, GermanyWe reviewed a contemporary single-center experience of a consecutive series of 448 patients with
mechanical composite aortic root replacement.We found significantly greater hospital mortality for
acute aortic root pathologic entities (type A dissection and infective endocarditis) but no effect of
the etiology on longevity after 30 days.S48 Aortic Surgery Symposium2012 discussions—Panel 1 (sessions I and II): Aortic
root, ascending aorta, and transcatheter aortic valve implantation (TAVI))
-
e
y
Table of Contents (continued)Panel 2 S56 Hypothermia for aortic surgery(continued on page 6A
The Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 3S 5ARandall B. Griepp, MD, and Gabriele Di Luozzo, MD, New York, NYHCA has been used during aortic arch repairs with acceptable neurologic outcomes. Through the
years, we have studied the effects of deep hypothermia on brain metabolism and perfusion both in
a pig model and in surgical patients. HCA has also been used as a method of organ protection in the
repair of thoracoabdominal aortic aneurysms. We summarize the clinical and laboratory studies to
support the routine use of HCA in clinical practice.S59 Selective cerebral perfusion: A review of the evidence
David Spielvogel, MD, Masashi Kai, MD, Gilbert H. L. Tang, MD, MSc, MBA,
Ramin Malekan, MD, and Steven L. Lansman, MD, PhD, Valhalla, NYHypothermic selective antegrade cerebral perfusion is widely used for aortic arch resection. We
review experimental and clinical evidence for optimum management of perfusion pressure, flow,
temperature, pH, hematocrit, and cannulation access for selective cerebral perfusion, and suggest
guidelines for its safe use.S63 Total arch replacement using antegrade cerebral perfusion
Yutaka Okita, MD, PhD, Kenji Okada, MD, PhD, Atsushi Omura, MD, Hiroya Kano, CE,
Hitoshi Minami, MD, PhD, Takeshi Inoue, MD, and Shunsuke Miyahara, MD, Kobe, JapanFrom January 2002 to May 2012, 423 consecutive patients (mean age, 69.2 6 13.1 years)
underwent total arch replacement using antegrade selective cerebral perfusion through a median
sternotomy. The surgical strategy consisted of meticulous selection of the arterial cannulation site
and type of the arterial cannula, antegrade selective cerebral perfusion, maintenance of the minimal
tympanic temperature between 20C and 23C, early rewarming immediately after distal
anastomosis, and maintenance of the fluid balance at less than 1000 mL during cardiopulmonary
bypass. AwovenDacron 4-branch graft was used in each patient. The overall hospital mortality was
4.5%, and permanent neurologic deficits occurred in 3.3% of patients. The risk factors for hospital
mortality were age more than 80 years, brain malperfusion, and long cardiopulmonary bypass time.
The overall survival at 10 years after surgery was 71.2% 6 5.0%.S72 Contemporary open aortic arch repair with selective cerebral perfusion in the
era of endovascular aortic repair
Yutaka Iba, MD, Kenji Minatoya, MD, PhD, Hitoshi Matsuda, MD, PhD, Hiroaki Sasaki, MD, PhD,
Hiroshi Tanaka, MD, PhD, Junjiro Kobayashi, MD, PhD, and Hitoshi Ogino, MD, PhD,
Suita, Osaka, and Shinjuku-ku, Tokyo, JapanThe results from the present retrospective study of about 1000 open arch repairs in the past
decade suggest that conventional open arch repair produces a satisfactory outcome in most
patients, excluding those at high risk, and is still the standard therapy, with good long-term
durability.S78 Reoperative surgery on the thoracic aorta
Roberto Di Bartolomeo, MD, Paolo Berretta, MD, Francesco D. Petridis, MD,
Gianluca Folesani, MD, Mariano Cefarelli, MD, Luca Di Marco, MD, PhD, and
Marco Di Eusanio, MD, PhD, Bologna, ItalyIn our experience, reinterventions on the proximal thoracic aorta were associated with favourable
outcomes, especially in electively operated individuals. The fact that progression of the aortic
disease represented the most common indication to reintervention suggests favoring aggressive
aortic resections at initial surgery.)
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Cardiovascular Surgery c March 2013Joseph Bavaria, MD, Prashanth Vallabhajosyula, MD, MS, Patrick Moeller, BS, Wilson Szeto, MD,
Nimesh Desai, MD, PhD, and Alberto Pochettino, MD, Philadelphia, PaThe hybrid approach to aortic arch aneurysm involving a zone 0 stent graft landing can be safely
adopted with good midterm results.S91 Transposition of the supra-aortic vessels before stent grafting the aortic arch
and descending aorta
Martin Czerny, MD, Martin Funovics, MD, Maria Schoder, MD, Christian Loewe, MD,
Johannes Lammer, MD, Martin Grabenw€oger, MD, J€urg Schmidli, MD, Thierry Carrel, MD, and
Michael Grimm, MD, Berne, Switzerland; and Vienna and Innsbruck, AustriaThis article summarizes the current status of combined vascular and endovascular approaches for
various multisegmental thoracic aortic pathology and provides the interested reader with an
strategy which approach to choose in which patients.S98 Elephant trunks in aortic surgery: Fresh and frozen
Christian Hagl, MD, Maximilian Pichlmaier, MD, MA, and Nawid Khaladj, MD, MBA,
Munich, GermanyWe discuss the pros and cons of different types of elephant trunk procedures (conventional vs
frozen) for the treatment of multifocal thoracic aortic aneurysms and dissections.S103 Advantage of a precurved fenestrated endograft for aortic arch disease:
Simplified arch aneurysm treatment in Japan 2010 and 2011
Yoshihiko Yokoi, MD, Takashi Azuma, MD, and Kenji Yamazaki, MD, PhD, Tokyo, JapanA precurved fenestrated endograft for endovascular repair in aortic arch disease rendered catheter
manipulation simple, minimized operative complication risks, and provided for appropriate
proximal landing. Acceptable clinical success and low incidences of stroke and early death were
achieved in early outcomes with this entirely endovascular arch aneurysm treatment.S110 Treatment of aortic arch aneurysms with a modular transfemoral
multibranched stent-graft: Initial experience
Cherrie Z. Abraham, BSc, BA, MD, FRCSC, and Christos Lioupis, PhD, EBSQ-Vasc,
Montreal, Quebec, CanadaWe present our initial experiece with a new modular transfemoral multibranched stent graft for the
treatment of aortic arch aneurysm. Six patients with arch pathology were treated with custom-made
branched arch endovascular stent grafts. Aneurysm exclusion without endoleak was achieved in
5 of 6 patients. The feasibility of this complex procedure has been shown in our initial series. Stroke
continues to be a worrisome complication specific to this method. A larger experience worldwide is
necessary before making any meaningful conclusions regarding the utility of this procedure.S118 Aortic Surgery Symposium 2012 discussions—Panel 2 (sessions III and IV):
Aortic archPanel 3 S123 A brief history of aortic surgery: Insight into distal aortic repair
Joseph S. Coselli, MD, and Susan Y. Green, MPH, Houston, Tex)
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Cardiovascular Surgery c March 2013Thoralf M. Sundt, MD, Boston, MassS130 The aortic wall: Four questions and insights
John A. Elefteriades, MD, Nicole Habel, MD, Wei Sun, PhD, Adam X. Sang, BA, andGregory A. Kuzmik, BA, New Haven, and Farmington, ConnS135 Visceral and spinal cord protection during thoracoabdominal aortic aneurysm
repair: Clinical and laboratory update
Gabriele Di Luozzo, MD, New York, NYVisceral and spinal cord complications after thoracoabdominal aortic aneurysm repair are
devastating. Both complications increase the perioperative mortality significantly. A variety of
perfusion techniques have been used to protect the viscera and spinal cord, with great success. We
have reviewed the techniques used in clinical practice and the most recent laboratory studies
regarding spinal cord protection.S139 Outcomes after thoracoabdominal aortic aneurysm repair using hypothermic
circulatory arrest
Nicholas T. Kouchoukos, MD, Alexander Kulik, MD, MPH, and Catherine F. Castner, RN,
St Louis, Mo, and Boca Raton, FlaAn experience with hypothermic cardiopulmonary bypass and circulatory arrest for repair of
thoracoabdominal aortic aneurysms is reported. The results compare favorably with other open
techniques and with endovascular repair, with particularly favorable outcomes in patients
undergoing elective repair.S142 Through the looking glass: The first 20 years of thoracic aortic stent-grafting
D. Craig Miller, MD, Stanford, CalifS149 Thoracic endovascular aortic repair: The basics
Nick Cheshire, MD, FRCS, and Colin Bicknell, MD, FRCS, London, UKS154 Update on blunt thoracic aortic injury: Fifteen-year single-institution experience
Anthony L. Estrera, MD, Charles C. Miller III, PhD, Gustavo Guajardo-Salinas, MD,
Sheila Coogan, MD, Kristofer Charlton-Ouw, MD, Hazim J. Safi, MD, and Ali Azizzadeh, MD,
Houston and El Paso TexWe report our experience with BTAI at a level 1 trauma center over the past 15 years. Early
mortality was significantly improved with TEVAR compared with open repair, with an overall
mortality reduction for BTAI.S159 Aortic Surgery Symposium 2012 discussions—Panel 3 (sessions V and VI):
Descending thoracic aorta, thoracoabdominal aorta, and traumaPanel 4 S165 Reintervention for endograft failures after thoracic endovascular aortic repair
Wilson Y. Szeto, MD, Nimesh D. Desai, MD, PhD, Patrick Moeller, BS, G. William Moser, CRNP,
Edward Y. Woo, MD, Ronald M. Fairman, MD, Alberto Pochettino, MD, and
Joseph E. Bavaria, MD, Philadelphia, PaEndograft failure after thoracic endovascular aortic repair remains a clinical concern and challenge.
Open and endovascular reinterventions can be performed with acceptable outcome. Treatment of
endograft failure should therefore be considered when indicated.)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 3S 9ANicola Troisi, MD, Samuele Bichi, MD, Davide Patrini, MD, Vincenzo Arena, MD,
Marco Setti, MD, Antonino Pitı, MD, and Giampiero Esposito, MD, Bergamo, ItalyTwelve patients with mega aorta syndrome underwent total replacement of the aorta with a 3-stage
hybrid repair. The second stagewas affected by non-negligible rates of perioperative complications.
The overall midterm results were encouraging.S178 Fibrinogen concentrate reduces intraoperative bleeding when used as first-line
hemostatic therapy during major aortic replacement surgery: Results from
a randomized, placebo-controlled trial
Niels Rahe-Meyer, MD, MSc, PhD, Alexander Hanke, MD, Dirk S. Schmidt, PhD,
Christian Hagl, MD, and Maximilian Pichlmaier, MD, Bielefeld, Hannover, Marburg, and Munich,
GermanyIn this randomized study of aortic surgery, the mean change in coagulopathic bleeding rate after
FIBTEM-guided fibrinogen concentrate was 248.3 g/5 min, versus 0.4 g/5 min after placebo
(P , .001), 216.1 g/5 min after 1 transfusion cycle (fresh-frozen plasma or platelets; P 5 .003),
and 228.0 g/5 min after 2 transfusion cycles (fresh-frozen plasma and platelets; P 5 .11).S186 Surgery for acute type A aortic dissection in octogenarians is justified
Gilbert H. L. Tang, MD, MSc, Ramin Malekan, MD, Cindy J. Yu, NP, Masashi Kai, MD,
Steven L. Lansman, MD, PhD, and David Spielvogel, MD, Valhalla, NYTwenty-one octogenarians were compared with 80 patients aged less than 80 years who underwent
acute type A dissection repair. Overall hospital mortality was 9%, with no in-hospital and no late
deaths among octogenarians. RAND SF-36 survey scores did not differ. Type A dissection surgery
should be offered to octogenarians.S191 Innominate artery cannulation: An alternative to femoral or axillary
cannulation for arterial inflow in proximal aortic surgery
Ourania Preventza, MD, Faisal G. Bakaeen, MD, Elizabeth H. Stephens, MD, PhD,
Susan M. Trocciola, MD, Kim I. de la Cruz, MD, and Joseph S. Coselli, MD, Houston, TexCannulation of the innominate artery is a safe, effective alternative to femoral or axillary
cannulation for arterial inflow in proximal aortic surgery procedures. Innominate artery cannulation
is especially useful in cases requiring hypothermic circulatory arrest to deliver antegrade cerebral
perfusion. An individualized approach is critical to ensure patient safety.S197 Simplified frozen elephant trunk repair for acute DeBakey type I dissection
Eric E. Roselli, MD, Aldo Rafael, MD, Edward G. Soltesz, MD, Leonardo Canale, MD, andBruce W. Lytle, MD, Cleveland, OhioA novel simplified hybrid technique for acute type I dissection allows for safe, effective, extended
aortic repair while promoting false lumen thrombosis and remodeling of the treated segment.
Implementation in a hybrid room allows for expedited definitive treatment in those with ischemia.
Long-term outcomes warrant continued investigation.)
Table of Contents (continued)S10A The Journal of Thoracic an202 Management of acute type B aortic dissectiond Cardiovascular Surgery c March 2013G. Chad Hughes, MD, Nicholas D. Andersen, MD, and Richard L. McCann, MD, Durham, NCTreatment options for acute type B aortic dissection are in a period of evolution as a result of the
influence of minimally invasive thoracic endovascular aortic repair. This review discusses the
contemporary management of acute type B aortic dissection and long-term treatment
considerations.S208 Importance of false lumen thrombosis in type B aortic dissection prognosis
Santi Trimarchi, MD, PhD, Jip L. Tolenaar, MD, Frederik H. W. Jonker, MD, PhD,
Brian Murray, MD, Thomas T. Tsai, MD, Kim A. Eagle, MD, Vincenzo Rampoldi, MD,
Hence J. M. Verhagen, MD, PhD, Joost A. van Herwaarden, MD, PhD, Frans L. Moll, MD, PhD,
Bart E. Muhs, MD, PhD, and John A. Elefteriades, MD, Milan, Italy; Rotterdam and Utrecht,
The Netherlands; New Haven, Conn; Denver, Colo; and Ann Arbor, MichThis study showed that, in medically treated ABAD patients, aortic segments with a partially
thrombosed false lumen have a significantly higher annual aortic growth rate when compared with
those presenting with patent and/or complete thrombosis. Therefore, patients with partial
thrombosis require more intensive follow-up and may benefit from prophylactic intervention.S213 Patients with type A acute aortic dissection presenting with major brain
injury: Should we operate on them?
Marco Di Eusanio, MD, PhD, Himanshu J. Patel, MD, Christoph A. Nienaber, MD, FACC, FESC,
Daniel M. Montgomery, BS, Amit Korach, MD, Thoralf M. Sundt, MD, Carlo DeVincentiis, MD,
Matthias Voehringer, MD, Mark D. Peterson, MD, PhD, Truls Myrmel, MD, PhD,
Gianluca Folesani, MD, Magnus Larsen, MD, Nimesh D. Desai, MD, Joseph E. Bavaria, MD,
Jehangir J. Appoo, MD, Teresa M. Kieser, MD, Rossella Fattori, MD, Kim Eagle, MD,
Roberto Di Bartolomeo, MD, and Santi Trimarchi, MD, Bologna and San Donato, Italy; Ann Arbor,
Mich; Rostock and Stuttgart, Germany; Jerusalem, Israel; Boston, Mass; Toronto, Ontario, and
Calgary, Alberta, Canada; Tromso, Norway; and Philadelphia, PaThe management strategy is controversial in patients with TA-AAD presenting with CVA or coma.
In the present observational study, patients selected to undergo surgery demonstrated improved late
survival and frequent reversal of neurologic deficits. Thus, in patients with TA-AAD and neurologic
injury, intervention should always be considered.S222 Aortic Surgery Symposium 2012 discussions—Panel 4 (sessions VII and VII):
Descending thoracic aorta, thoracaobadominal aorta, and dissectionReader Services 11A Information for ReadersCover Photograph
From Hybrid Approaches in the Treatment of Aortic Arch Aneurysms: Postoperative and Midterm Outcomes. Hybrid aortic arch
repair, types I, II, and III.
